![Klaus Orlinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Klaus Orlinger is currently the Chief Scientific Officer at HOOKIPA Pharma, Inc. He started this position in 2022.
Dr. Orlinger has an educational background, having obtained undergraduate, graduate, and doctorate degrees from the University of Vienna.
| Unternehmen | Position | Beginn |
|---|---|---|
| HOOA PHARPAR | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
University of Vienna
 University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
